Oncology & Cancer

Study reports higher rates of cancer in developed countries

Developed countries, with greater access to healthcare, experience much higher rates of cancer incidence than the world's "worse off" countries, according to new research from the University of Adelaide.

Oncology & Cancer

Cancer cells' universal 'dark matter' exposed

Using the latest gene sequencing tools to examine so-called epigenetic influences on the DNA makeup of colon cancer, a Johns Hopkins team says its results suggest cancer treatment might eventually be more tolerable and successful ...

Health

Acupuncture equals disease prevention say new studies

Well-recognized for its therapeutic effects, acupuncture is increasingly being appreciated for its ability to promote wellness and contribute to the prevention of a broad range of conditions. A new study, which demonstrates ...

Health

Pressure builds to ban dietary supplement DMAA

Joseph Perez used to gear up for his intense workouts by taking ephedra-based dietary supplements. When they were banned because of safety concerns, Perez turned to an even more potent stimulant called DMAA.

page 1 from 7

Nature Medicine

Nature Medicine is an academic journal publishing research articles, reviews, news and commentaries in the biomedical area, including both basic research and early-phase clinical research. Topics covered include cancer, cardiovascular disease, gene therapy, immunology, vaccines and neuroscience. The journal seeks to publish research papers that 'demonstrate novel insight into disease processes, with direct evidence of the physiological relevance of the results.'

Founded in 1995, Nature Medicine is published by the Nature Publishing Group, a division of Macmillan Publishers Ltd, and is one of the rapidly expanding stable of Nature journals. Like other Nature journals, there is no external Editorial Board, with editorial decisions being made by an in-house team, although peer review by external expert referees forms a part of the review process.

Nature Medicine is published monthly. Articles are archived online in text and PDF formats; access is by subscription only.

Its 2007 impact factor was 26.382, making it the highest cited research journal in preclinical medicine. It is also among the highest impact of primary (non-review) scientific journals.

This text uses material from Wikipedia, licensed under CC BY-SA